{"transactions":[{"id":3517532,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2019-05-21T10:38:29.000Z","date":"2019-05-18","kind":"exercise","acquired":false,"shares":30875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on May 18, 2017 and vested on May 18, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on May 18, 2017 and vested on May 18, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":30875},"source":{"system":"sec-edgar","filing":"0001209191-19-031609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031609/doc4.xml","form_type":"4"}},{"id":3517531,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2019-05-21T10:38:29.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":16070,"price":11.42,"value":183519.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."}],"balance_after":33588.727,"source":{"system":"sec-edgar","filing":"0001209191-19-031609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031609/doc4.xml","form_type":"4"}},{"id":3517530,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2019-05-21T10:38:29.000Z","date":"2019-05-18","kind":"exercise","acquired":true,"shares":30875,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":49658.727,"source":{"system":"sec-edgar","filing":"0001209191-19-031609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031609/doc4.xml","form_type":"4"}},{"id":3519582,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2019-05-20T11:18:18.000Z","date":"2019-05-16","kind":"exercise","acquired":false,"shares":1204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 12, 2019 pursuant to the satisfaction of performance criteria and vested on May 16, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 12, 2019 pursuant to the satisfaction of performance criteria and vested on May 16, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1204},"source":{"system":"sec-edgar","filing":"0001209191-19-031213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031213/doc4.xml","form_type":"4"}},{"id":3519581,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2019-05-20T11:18:18.000Z","date":"2019-05-16","kind":"sale","acquired":false,"shares":629,"price":11.76,"value":7397.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."}],"balance_after":18783.727,"source":{"system":"sec-edgar","filing":"0001209191-19-031213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031213/doc4.xml","form_type":"4"}},{"id":3519580,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2019-05-20T11:18:18.000Z","date":"2019-05-16","kind":"exercise","acquired":true,"shares":1204,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Ordinary Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units."}],"balance_after":19412.727,"source":{"system":"sec-edgar","filing":"0001209191-19-031213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031213/doc4.xml","form_type":"4"}},{"id":3609901,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2019-03-06T12:08:28.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":74626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 24,875 vesting on each of March 4, 2021 and March 4, 2022 and 24,876 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 24,875 vesting on each of March 4, 2021 and March 4, 2022 and 24,876 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":74626,"derivative":{"underlying":"Ordinary Shares","underlying_shares":74626},"source":{"system":"sec-edgar","filing":"0001209191-19-017228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119017228/doc4.xml","form_type":"4"}},{"id":3651691,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2019-02-19T12:05:06.000Z","date":"2019-02-14","kind":"exercise","acquired":false,"shares":9280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 14, 2017, with 9,280 vesting on each of February 14, 2019, February 14, 2020 and February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 14, 2017, with 9,280 vesting on each of February 14, 2019, February 14, 2020 and February 14, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":18560,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9280},"source":{"system":"sec-edgar","filing":"0001209191-19-010835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119010835/doc4.xml","form_type":"4"}},{"id":3651690,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2019-02-19T12:05:06.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":3192,"price":17.669,"value":56399.448,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $17.675, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":18208.727,"source":{"system":"sec-edgar","filing":"0001209191-19-010835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119010835/doc4.xml","form_type":"4"}},{"id":3651689,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2019-02-19T12:05:06.000Z","date":"2019-02-14","kind":"exercise","acquired":true,"shares":9280,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":21400.727,"source":{"system":"sec-edgar","filing":"0001209191-19-010835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119010835/doc4.xml","form_type":"4"}},{"id":3658627,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2019-02-14T12:43:49.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":1204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time based vesting and will vest on May 16, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time based vesting and will vest on May 16, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1204,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1204},"source":{"system":"sec-edgar","filing":"0001209191-19-009989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119009989/doc4.xml","form_type":"4"}},{"id":3658626,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2019-02-14T12:43:49.000Z","date":"2019-02-13","kind":"sale","acquired":false,"shares":5041,"price":17.875,"value":90107.875,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the performance share units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.86 to $17.88, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12120.727,"source":{"system":"sec-edgar","filing":"0001209191-19-009989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119009989/doc4.xml","form_type":"4"}},{"id":3658625,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2019-02-14T12:43:49.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":14432,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Ordinary Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units."}],"balance_after":17161.727,"source":{"system":"sec-edgar","filing":"0001209191-19-009989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119009989/doc4.xml","form_type":"4"}},{"id":4067047,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2018-02-12T21:17:16.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":62690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 20,896 vesting on each of February 9, 2020 and February 9, 2021 and 20,898 vesting on February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 20,896 vesting on each of February 9, 2020 and February 9, 2021 and 20,898 vesting on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":62690,"derivative":{"underlying":"Ordinary Shares","underlying_shares":62690},"source":{"system":"sec-edgar","filing":"0001209191-18-009181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009181/doc4.xml","form_type":"4"}},{"id":4067046,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":157357,"kind":"person","name":"de Notaristefani Carlo","position":1,"cik":"0001719114","reported_name":"de Notaristefani Carlo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Stock Options (right to buy)","published_at":"2018-02-12T21:17:16.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":159819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options were granted on February 9, 2018, with 53,273 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":159819,"derivative":{"exercise_price":18.61,"expiration_date":"2028-02-08","underlying":"Ordinary Shares","underlying_shares":159819},"source":{"system":"sec-edgar","filing":"0001209191-18-009181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009181/doc4.xml","form_type":"4"}}]}